CurrentCapital BluecrossPolicy MP 4.041

Dry Needling of Trigger Points for Myofascial Pain

This policy governs coverage determinations for dry needling of myofascial trigger points for members of Capital BlueCross benefit programs and specifies that the procedure is investigational and not supported as medically necessary by available evidence.

Policy Summary

PayerCapital Bluecross

PolicyDry Needling of Trigger Points for Myofascial Pain

Policy CodePolicy MP 4.041

Change TypeNo material change

Effective DateAug 1, 2025

Next Review Date

Key ActionDo not expect coverage for dry needling; verify member benefits and prior authorization requirements as investigational services may be denied.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

InvestigationalCoverage stance

20560,20561,20999Procedure codes

08/01/2025Effective

InsufficientEvidence

Coverage Determinations

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Investigational / Not Medically Necessary

Covered when ALL of the following are met:

Policy stance: Dry needling of trigger points for the treatment of myofascial pain is considered investigational due to insufficient evidence to support a general conclusion concerning health outcomes or benefits.

Applies across indications reviewed (neck/shoulder, plantar heel pain, temporomandibular myofascial pain).

This policy applies to specific programs and products administered by Capital BlueCross and is subject to member benefit variations. Refer to the member's specific benefit plan language for coverage details and any program-specific rules (for example, FEP PPO members should be directed to the FEP Medical Policy Manual). Eligibility, coverage, and any prior authorization requirements depend on the member's benefit contract.

Dry needling of trigger points for the treatment of myofascial pain is designated investigational and therefore not covered. Services billed with the procedure codes identified in the coding section may be denied as investigational; coverage determinations are subject to the member’s benefit terms and contract.

Provider Requirements and Billing Impact

Prior Authorization

Prior Authorization and Product Variation — Applicability

This policy is only applicable to certain programs and products administered by Capital Blue Cross and may be subject to member benefit variations. Providers should verify the member's specific benefit plan for prior authorization requirements and coverage details.

FEP PPO: Refer to the FEP Medical Policy Manual at https://www.fepblue.org/benefit-plans/medical-policies-and-utilization-managementguidelines/medical-policies

Note

Provider Action

Providers: Verify member eligibility and benefits and submit all required clinical documentation to support medical necessity. Contact Capital Blue Cross if there is uncertainty about coverage for dry needling under the member's plan.

Documentation Required

Claims Processing and Documentation

Claims are subject to the member's benefit program, eligibility on the date of service, and medical necessity determinations. Final claim payment is based on the terms of the member's contract, including limitations and exclusions. Ensure documentation supports the medical necessity of services billed.

Denial Risk

Denial Risk for Investigational Procedure

Services billed with codes such as 20560, 20561, and 20999 for dry needling or related procedures may be denied as investigational. Providers should review member benefits and consider alternative coding or prior authorization where applicable.

Affected CPT / procedure codes: 20560, 20561, 20999

Clinical Background

Myofascial trigger points are discrete, focal, hyperirritable spots within a taut band of skeletal muscle fibers that produce local and/or referred pain when stimulated. Dry needling involves insertion of a fine needle into the skin and muscle at sites of myofascial pain without injection of medication; techniques include superficial approaches that target mechanoreceptors and deep approaches that may elicit a local twitch response to inactivate trigger points. Clinical rationale for these procedures centers on modifying local muscle physiology and pain signaling, but available evidence is insufficient to establish consistent health benefit across reviewed indications.

Key Definitions

Myofascial trigger point

TermMyofascial trigger point

DefinitionDiscrete, focal, hyperirritable spot within a taut band of skeletal muscle fibers that produces local and/or referred pain when stimulated.

Associated featuresLinked to local ischemia, hypoxia, lowered pH, local and referred pain, and altered muscle activation patterns.

Dry needling

TermDry needling

DefinitionInsertion of a fine needle into the skin and muscle at a site of myofascial pain, performed without injection of medications, intended to stimulate underlying myofascial trigger points, muscles, and connective tissues to manage myofascial pain.

TechniquesMay include deep dry needling (aims to elicit local twitch response to inactivate trigger points) and superficial dry needling (targets mechanoreceptors to modulate pain).

Needle types and durationPerformed with acupuncture or standard hypodermic needles; needle may be moved, rotated, or left in place for up to 30 minutes.